. We need to avoid the blind use of publication counts or total funding support in prospective and retrospective research evaluations, including grant reviews.
We have to collectively think of a new strategy to avoid the occasional resemblance of the NIH grant review system to the evaluation of amateur singers on American Idol ("nasty reviewer always wins"). However, we also need to avoid the pitfalls of Pagano's proposed strategy where a potential Big Brother ranking system could result in subjective judgements about grant applications and a bias in favor of large labs and established investigators.
Ivo D. Dinov 1,
Many scientists and NIH administrators are convinced that the NIH grant review process, which was not designed for the current large number of applications and the concomitant low success rates, needs some urgent adjustments to save money and time for both applicants and reviewers. My recent Correspondence in Cell (Pagano, 2006) was not intended to provide a magic solution for fixing the NIH grant review process. Rather, its purpose was to stimulate a constructive discussion. Therefore, it is not my intention to defend my proposal as if it were the only solution.
The shortcomings of NIH grant review (the current system or possible alternatives) become less problematic when the NIH payline is around 25%-30%, as it was just a few years ago. However, now that the payline is down to 9%-13% (depending on the different NIH institutes), faultlines are beginning to appear. Whereas topand low-score applications are easily identified using a variety of methods, there is a strong level of subjectivity and luck for those applications falling between the 10th and 20th percentile. The current number of worthwhile applications is higher than the number that can be funded. Hence, the real issue is money. The public, Congress, the NIH, and the scientific community need to work together to increase the NIH budget as soon as possible and to make sure that more funds are directed to finance R01 grants (Mandel and Vesell, 2006; Weinberg, 2006) . A steady payline of around 20% would certainly be advantageous, balancing the need for funding stability with the requirement for high-caliber science. Large differences in paylines arising during the course of only a few years generate serious problems for R01 applicants, a scenario that we have witnessed over the last few years. In fact, the support of mediocre science during periods of high NIH funding directly influences the payline during subsequent periods of lower budgets-even when budget cuts are relatively minor-because each grant is supported with a commitment of 4 to 5 years. In addition to affecting individual labs, large payline oscillations cause huge difficulties for academic institutions that grow during periods of good funding but then need to shrink in response to cuts.
Clearly, until the funding situation is resolved (hopefully for the best), it is important to discuss how to improve the NIH grant review process. Different systems of peer review offer various advantages and disadvantages.
Response: More Money and Less Time!
In the end, multiple approaches may be equally valid and successful, including the system that I proposed in my recent article.
I believe that shortening grant applications would represent a simple solution to save money and time. Compared to other grant applications, NIH applications, at 25 pages, are probably the longest. Grant applications to the US National Science Foundation, The Wellcome Trust, and the Howard Hughes Medical Institute comprise 15, 6, and 5 pages, respectively. Applications to government agencies in the UK, Australia, Canada, and Israel require between 8 and 15 pages. In most cases, review of these grants also differs from the NIH system. For example, it often takes place through mail or email, which generally guarantees that the same reviewer will evaluate revised proposals and that his/her expertise is not confined to just a single study section. Some agencies prefer to disclose the names of the reviewers (to diminish the possibility of inflated critiques), whereas others opt for an anonymous system (to avoid understated critiques of reviewers hesitant to be unfavorable to established or well-connected investigators). Finally, in the case of many agencies, compared to applications for new grants, those for competing grant renewals are simplified and much more retrospective than prospective (Marks, 2006; Nurse, 2006 administrators. Nevertheless, as I mention above, I do not believe that there is a unique path to our common goal: to find a way to make the process cheaper and easier and to alleviate the workload of applicants and reviewers. The scientific community has too many important and serious things to do. If a mind is a terrible thing to waste, wasting money and time is outrageous and senseless.
Michele Pagano
1, *
